[1] |
方三高, 魏建国, 陈真伟. WHO(2020)软组织肿瘤分类[J]. 临床与实验病理学杂志, 2020, 36(9):1132-1134.
|
[2] |
Battistella E, Pomba L, Mirabella M, et al. Metastatic adrenal PEComa: case report and short review of the literature[J]. Medicina, 2023, 59(1):149.
|
[3] |
Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature[J]. Am J Surg Pathol, 2005, 29(12):1558-1575.
|
[4] |
刘彬, 刘符生, 郝星源, 等. 肝脏血管周上皮样细胞瘤3例报道及文献复习[J]. 腹部外科, 2023, 36(4):313-318, 323.
|
[5] |
Klompenhouwer AJ, Verver D, Janki S, et al. Management of hepatic angiomyolipoma: a systematic review[J]. Liver Int, 2017, 37(9):1272-1280.
|
[6] |
Huber C, Treutner KH, Steinau G, et al. Ruptured hepatic angiolipoma in tuberous sclerosis complex[J]. Langenbecks Arch Chir, 1996, 381(1):7-9.
|
[7] |
Guidi G, Catalano O, Rotondo A. Spontaneous rupture of a hepatic angiomyolipoma: CT findings and literature review[J]. Eur Radiol, 1997, 7(3):335-337.
|
[8] |
Tsui WM, Colombari R, Portmann BC, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants[J]. Am J Surg Pathol, 1999, 23(1):34-48.
|
[9] |
Zhou YM, Li B, Xu F, et al. Clinical features of hepatic angiomyolipoma[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3):284-287.
|
[10] |
Ding GH, Liu Y, Wu MC, et al. Diagnosis and treatment of hepatic angiomyolipoma[J]. J Surg Oncol, 2011, 103(8):807-812.
|
[11] |
Occhionorelli S, Dellachiesa L, Stano R, et al. Spontaneous rupture of a hepatic epithelioid angiomyolipoma: damage control surgery. a case report[J]. G Chir, 2013, 34(11/12):320-322.
|
[12] |
Tajima S, Suzuki A, Suzumura K. Ruptured hepatic epithelioid angiomyolipoma: a case report and literature review[J]. Case Rep Oncol, 2014, 7(2):369-375.
|
[13] |
Aoki H, Arata T, Morihiro T, et al. Spontaneous rupture of a hepatic angiomyolipoma: report of a case[J]. Clin J Gastroenterol, 2014, 7(5):429-433.
|
[14] |
Kai K, Miyosh A, Aishima S, et al. Granulomatous reaction in hepatic inflammatory angiomyolipoma after chemoembolization and spontaneous rupture[J]. World J Gastroenterol, 2015, 21(32):9675-9682.
|
[15] |
陈伯柱, 周正扬. 肝脏血管平滑肌脂肪瘤破裂出血1例并文献复习[J]. 中外医学研究, 2015, 13(18):109-111.
|
[16] |
Kim SH, Kang TW, Lim K, et al. A case of ruptured hepatic angiomyolipoma in a young male[J]. Clin Mol Hepatol, 2017, 23(2):179-183.
|
[17] |
D'Silva M, Na HY, Cho JY, et al. Diagnosis and surgical treatment of a rare hepatic angiomyolipoma with internal hemorrhage[J]. Ann Hepatobiliary Pancreat Surg, 2021, 25(4):532-535.
|
[18] |
陈凯, 杨光, 韩克强, 等. 巨大肝脏血管平滑肌脂肪瘤自发性破裂一例[J]. 肝胆胰外科杂志, 2021, 33(7):448-449.
|
[19] |
Velasco-Albendea FJ, Gil-Belmonte MJ, Estébanez-Ferrero B, et al. A case report of hepatic angiomyolipoma, inflammatory subtype. clinico-pathological characterization: a diagnostic challenge[J]. Diagn Pathol, 2023, 18(1):57.
|
[20] |
沈强, 王国松. 肝脏血管平滑肌脂肪瘤破裂出血1例[J]. 医学影像学杂志, 2023, 33(2):274, 278.
|
[21] |
Nie P, Wu J, Wang H, et al. Primary hepatic perivascular epithelioid cell tumors: imaging findings with histopathological correlation[J]. Cancer Imaging, 2019, 19(1):32.
|
[22] |
张倩, 牛猛, 姬健智, 等. 肾外腹膜后血管平滑肌脂肪瘤2例报道及文献复习[J]. 医学影像学杂志, 2022, 32(3):538-540.
|
[23] |
Liu J, Zhang CW, Hong DF, et al. Primary hepatic epithelioid angiomyolipoma: a malignant potential tumor which should be recognized[J]. World J Gastroenterol, 2016, 22(20):4908-4917.
|
[24] |
Yeh CN, Lee KF, Chen MF. Immunohistochemical study of hepatic angiomyolipoma[J]. Hepatogastroenterology, 2005, 52(64):1151-1153.
|
[25] |
张晓妮, 傅潇, 任梦迪, 等. 血管周上皮样细胞肿瘤的研究进展[J]. 现代肿瘤医学, 2022, 30(8):1517-1520.
|
[26] |
Leong WHJ, Tan XHA, Salazar E. More than pus-primary hepatic epithelioid angiomyolipoma masquerading as liver abscess[J]. Case Rep Gastroenterol, 2021, 15(1):1-8.
|
[27] |
Yang X, Lei C, Qiu Y, et al. Selecting a suitable surgical treatment for hepatic angiomyolipoma: a retrospective analysis of 92 cases[J]. ANZ J Surg, 2018, 88(9):E664-669.
|
[28] |
Calame P, Tyrode G, Weil Verhoeven D, et al. Clinical characteristics and outcomes of patients with hepatic angiomyolipoma: a literature review[J]. World J Gastroenterol, 2021, 27(19):2299-2311.
|
[29] |
Nguyen CL, Nguyen HH, Luong TH, et al. Giant hepatic angiomyolipoma presenting with severe anemia: a surgical case report and review of literature[J]. Int J Surg Case Rep, 2022, 94: 107087.
|
[30] |
Schoolmeester JK, Howitt BE, Hirsch MS, et al. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of16 cases[J]. Am J Surg Pathol, 2014, 38(2):176-188.
|
[31] |
Bennett JA, Braga AC, Pinto A, et al. Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors[J]. Am J Surg Pathol, 2018, 42(10):1370-1383.
|
[32] |
龙卫国, 郑芳, 李梅, 等. 肝脏血管周上皮样细胞肿瘤的临床病理分析[J]. 安徽医药, 2018, 22(3):445-449.
|
[33] |
Kamimura K, Oosaki A, Sugahara S, et al. Malignant potential of hepatic angiomyolipoma: case report and literature review[J]. Clin J Gastroenterol, 2010, 3(2):104-110.
|
[34] |
白杨, 孙璐, 郭爱桃, 等. 肝恶性血管周上皮样细胞肿瘤4例临床病理分析[J]. 诊断病理学杂志, 2014, 21(2):73-75, 79.
|
[35] |
Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system[J]. Histopathology, 2020, 76(2):182-188.
|
[36] |
夏杰, 杨成林, 唐紫萌, 等. 肝脏恶性上皮样血管周细胞瘤的诊断与外科治疗[J]. 肝胆胰外科杂志, 2020, 32(12):719-722, 726.
|
[37] |
Zhou Y, Chen F, Jiang W, et al. Hepatic epithelioid angiomyolipoma with an unusual pathologic appearance: expanding the morphologic spectrum[J]. Int J Clin Exp Pathol, 2014, 7(9):6364-6369.
|
[38] |
Parfitt JR, Bella AJ, Izawa JI, et al. Malignant neoplasm of perivascular epithelioid cells of the liver[J]. Arch Pathol Lab Med, 2006, 130(8):1219-1222.
|
[39] |
Chang ZG, Zhang JM, Ying JQ, et al. Characteristics and treatment strategy of hepatic angiomyolipoma: a series of 94 patients collected from four institutions[J]. J Gastrointestin Liver Dis, 2011, 20(1):65-69.
|
[40] |
Mao JX, Yuan H, Sun KY, et al. Pooled analysis of hepatic inflammatory angiomyolipoma[J]. Clin Res Hepatol Gastroenterol, 2020, 44(6):e145-151.
|
[41] |
宣兰兰, 魏建国, 刘红刚. 血管周上皮样细胞肿瘤的病理诊断及新进展[J]. 中华病理学杂志, 2021, 50(3):282-287.
|
[42] |
赵苏苏, 余慧萍, 徐佳佳, 等. 肝脏血管周上皮样细胞肿瘤的临床病理观察[J]. 临床肿瘤学杂志, 2023, 28(3):258-262.
|
[43] |
Yang X, Wang Q, Zhou X, et al. Retrospective analysis of hepatic perivascular epithelioid cell tumour (PEComa) in a single centre for clinical diagnosis and treatment clinical diagnosis and treatment of hepatic PEComa[J]. Medicine, 2022, 101(25):e29506.
|
[44] |
Hornick JL, Fletcher CD. Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum[J]. Am J Surg Pathol, 2008, 32(4):493-501.
|
[45] |
叶郁红, 张声, 王行富. 肝脏恶性血管周上皮样细胞瘤临床病理观察[J]. 中国现代医生, 2009, 47(32):98-100, 161.
|
[46] |
Gulavita P, Fletcher CDM, Hirsch MS. PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours[J]. Histopathology, 2018, 72(3):441-448.
|
[47] |
Goodman ZD, Ishak KG. Angiomyolipomas of the liver[J]. Am J Surg Pathol, 1984, 8(10):745-750.
|
[48] |
Jia J, Luo J, Pan CG, et al. Single-center experience in the diagnosis and treatment of hepatic perivascular epithelioid cell neoplasm[J]. J Clin Transl Hepatol, 2022, 10(1):72-79.
|
[49] |
Yang X, Li A, Wu M. Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases[J]. Med Oncol, 2013, 30(1):416.
|
[50] |
Yang CY, Ho MC, Jeng YM, et al. Management of hepatic angiomyolipoma[J]. J Gastrointest Surg, 2007, 11(4):452-457.
|
[51] |
Klompenhouwer AJ, Dwarkasing RS, Doukas M, et al. Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome[J]. HPB, 2020, 22(4):622-629.
|
[52] |
Ge XW, Zeng HY, Su-Jie A, et al. Hepatocellular carcinoma with concomitant hepatic angiomyolipoma and cavernous hemangioma in one patient[J]. World J Gastroenterol, 2015, 21(11):3414-3419.
|
[53] |
Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver: a collective review[J]. J Gastroenterol, 1994, 29(1):95-105.
|
[54] |
Hooper LD, Mergo PJ, Ros PR. Multiple hepatorenal angiomyolipomas: diagnosis with fat suppression, gadolinium-enhanced MRI[J]. Abdom Imaging, 1994, 19(6):549-551.
|
[55] |
Mochizuki K, Aoki T, Kusano T, et al. Laparoscopic resection of a hepatic epithelioid angiomyolipoma revealed by indocyanine green fluorescence imaging[J]. Am Surg, 2023, 89(5):2061-2063.
|
[56] |
Kamimura K, Nomoto M, Aoyagi Y. Hepatic angiomyolipoma: diagnostic findings and management[J]. Int J Hepatol, 2012: 410781.
|
[57] |
Dumortier J, Guillaud O, Walter T, et al. Liver transplantation for multiple angiomyolipomas complicating tuberous sclerosis complex[J]. Gastroenterol Clin Biol, 2010, 34(8/9):494-498.
|
[58] |
Kirste S, Kayser G, Zipfel A, et al. Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection[J]. Radiat Oncol, 2018, 13(1):28.
|
[59] |
Bergamo F, Maruzzo M, Basso U, et al. Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa)[J]. World J Surg Oncol, 2014, 12:46.
|
[60] |
Wang WT, Li ZQ, Zhang GH, et al. Liver transplantation for recurrent posthepatectomy malignant hepatic angiomyolipoma: a case report[J]. World J Gastroenterol, 2015, 21(12):3755-3758.
|
[61] |
Vagefi PA, Eilers H, Hiniker A, et al. Liver transplantation for giant hepatic angiomyolipoma[J]. Liver Transpl, 2011, 17(8):985-986.
|
[62] |
Inoki K, Li Y, Xu T, et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling[J]. Genes Dev, 2003, 17(15):1829-1834.
|
[63] |
Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2):a multicentre, randomised, double-blind, placebo-controlled trial[J]. Lancet, 2013, 381(9869):817-824.
|
[64] |
Franz DN, Belousova E, Sparagana S, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial[J]. Lancet, 2013, 381(9861):125-132.
|
[65] |
Mizuguchi M, Ikeda H, Kagitani-Shimono K, et al. Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan[J]. Brain Dev, 2019, 41(1):1-10.
|
[66] |
Wataya-Kaneda M, Nakamura A, Tanaka M, et al. Efficacy and safety of topical sirolimus therapy for facial angiofibromas in the tuberous sclerosis complex: a randomized clinical trial[J]. JAMA Dermatol, 2017, 153(1):39-48.
|
[67] |
Kenerson H, Folpe AL, Takayama TK, et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms[J]. Hum Pathol, 2007, 38(9):1361-1371.
|
[68] |
Dickson MA, Schwartz GK, Antonescu CR, et al. Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates[J]. Int J Cancer, 2013, 132(7):1711-1717.
|
[69] |
Jia R, Jiang L, Zhou Y, et al. Clinical features of 18 perivascular epithelioid cell tumor cases[J]. Medicine, 2020, 99(34):e21659.
|
[70] |
Italiano A, Delcambre C, Hostein I, et al. Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa[J]. Ann Oncol, 2010, 21(5):1135-1137.
|
[71] |
O'Malley ME, Chawla TP, Lavelle LP, et al. Primary perivascular epithelioid cell tumors of the liver: CT/MRI findings and clinical outcomes[J]. Abdom Radiol, 2017, 42(6):1705-1712.
|
[72] |
Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis[J]. N Engl J Med, 2008, 358(2):140-151.
|
[73] |
Agaram NP, Sung YS, Zhang L, et al. Dichotomy of genetic abnormalities in PEComas with therapeutic implications[J]. Am J Surg Pathol, 2015, 39(6):813-825.
|
[74] |
Sanfilippo R, Jones RL, Blay JY, et al. Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas)[J]. Clin Cancer Res, 2019, 25(17):5295-5300.
|
[75] |
Xu J, Gong XL, Wu H, et al. Case report: gastrointestinal PEComa with TFE3 rearrangement treated with anti-VEGFR TKI apatinib[J]. Front Oncol, 2020, 10:582087.
|